259 related articles for article (PubMed ID: 35653631)
1. NF-κB-dependent secretome of senescent cells can trigger neuroendocrine transdifferentiation of breast cancer cells.
Raynard C; Ma X; Huna A; Tessier N; Massemin A; Zhu K; Flaman JM; Moulin F; Goehrig D; Medard JJ; Vindrieux D; Treilleux I; Hernandez-Vargas H; Ducreux S; Martin N; Bernard D
Aging Cell; 2022 Jul; 21(7):e13632. PubMed ID: 35653631
[TBL] [Abstract][Full Text] [Related]
2. Atractylenolide III suppresses senescence-associated secretome via inhibiting cGAS/NF-κB pathway in hepatic stellate cells.
Wu H; Wu L; Xiao L; Gu Y; Liu H; Zhang L; Zhang M; Qi L
Clin Exp Pharmacol Physiol; 2023 Apr; 50(4):316-324. PubMed ID: 36648378
[TBL] [Abstract][Full Text] [Related]
3. Senescent Secretome of Blind Mole Rat
Odeh A; Eddini H; Shawasha L; Chaban A; Avivi A; Shams I; Manov I
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982207
[TBL] [Abstract][Full Text] [Related]
4. CD36 initiates the secretory phenotype during the establishment of cellular senescence.
Chong M; Yin T; Chen R; Xiang H; Yuan L; Ding Y; Pan CC; Tang Z; Alexander PB; Li QJ; Wang XF
EMBO Rep; 2018 Jun; 19(6):. PubMed ID: 29777051
[TBL] [Abstract][Full Text] [Related]
5. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
Malaquin N; Rodier F
Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
[TBL] [Abstract][Full Text] [Related]
6. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype.
Malaquin N; Martinez A; Rodier F
Exp Gerontol; 2016 Sep; 82():39-49. PubMed ID: 27235851
[TBL] [Abstract][Full Text] [Related]
7. Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells.
Perrott KM; Wiley CD; Desprez PY; Campisi J
Geroscience; 2017 Apr; 39(2):161-173. PubMed ID: 28378188
[TBL] [Abstract][Full Text] [Related]
8. The senescence-associated secretory phenotype and its regulation.
Lopes-Paciencia S; Saint-Germain E; Rowell MC; Ruiz AF; Kalegari P; Ferbeyre G
Cytokine; 2019 May; 117():15-22. PubMed ID: 30776684
[TBL] [Abstract][Full Text] [Related]
9. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells.
Alessio N; Aprile D; Squillaro T; Di Bernardo G; Finicelli M; Melone MA; Peluso G; Galderisi U
Aging (Albany NY); 2019 Aug; 11(15):5817-5828. PubMed ID: 31412320
[TBL] [Abstract][Full Text] [Related]
10. Role of Clusterin/NF-κB in the secretion of senescence-associated secretory phenotype in Cr(VI)-induced premature senescent L-02 hepatocytes.
Liang Y; Liang N; Ma Y; Tang S; Ye S; Xiao F
Ecotoxicol Environ Saf; 2021 Aug; 219():112343. PubMed ID: 34020271
[TBL] [Abstract][Full Text] [Related]
11. Punicalagin induces senescent growth arrest in human papillary thyroid carcinoma BCPAP cells via NF-κB signaling pathway.
Cheng X; Yao X; Xu S; Pan J; Yu H; Bao J; Guan H; Lu R; Zhang L
Biomed Pharmacother; 2018 Jul; 103():490-498. PubMed ID: 29677534
[TBL] [Abstract][Full Text] [Related]
12. Senescence-induced endothelial phenotypes underpin immune-mediated senescence surveillance.
Yin K; Patten D; Gough S; de Barros Gonçalves S; Chan A; Olan I; Cassidy L; Poblocka M; Zhu H; Lun A; Schuijs M; Young A; Martinez-Jimenez C; Halim TYF; Shetty S; Narita M; Hoare M
Genes Dev; 2022 May; 36(9-10):533-549. PubMed ID: 35618311
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of BAFF on the senescence-associated secretome and growth arrest.
Rossi M; Anerillas C; Idda ML; Munk R; Shin CH; Donega S; Tsitsipatis D; Herman AB; Martindale JL; Yang X; Piao Y; Mazan-Mamczarz K; Fan J; Ferrucci L; Johnson PF; De S; Abdelmohsen K; Gorospe M
Elife; 2023 Apr; 12():. PubMed ID: 37083495
[TBL] [Abstract][Full Text] [Related]
14. Potential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging.
Han X; Lei Q; Xie J; Liu H; Li J; Zhang X; Zhang T; Gou X
J Gerontol A Biol Sci Med Sci; 2022 Nov; 77(11):2207-2218. PubMed ID: 35524726
[TBL] [Abstract][Full Text] [Related]
15. Isolation methodology is essential to the evaluation of the extracellular vesicle component of the senescence-associated secretory phenotype.
Wallis R; Josipovic N; Mizen H; Robles-Tenorio A; Tyler EJ; Papantonis A; Bishop CL
J Extracell Vesicles; 2021 Feb; 10(4):e12041. PubMed ID: 33659050
[TBL] [Abstract][Full Text] [Related]
16. Non-canonical ATM/MRN activities temporally define the senescence secretory program.
Malaquin N; Olivier MA; Martinez A; Nadeau S; Sawchyn C; Coppé JP; Cardin G; Mallette FA; Campisi J; Rodier F
EMBO Rep; 2020 Oct; 21(10):e50718. PubMed ID: 32785991
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological CDK4/6 inhibition reveals a p53-dependent senescent state with restricted toxicity.
Wang B; Varela-Eirin M; Brandenburg SM; Hernandez-Segura A; van Vliet T; Jongbloed EM; Wilting SM; Ohtani N; Jager A; Demaria M
EMBO J; 2022 Mar; 41(6):e108946. PubMed ID: 34985783
[TBL] [Abstract][Full Text] [Related]
18. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
Malaquin N; Tu V; Rodier F
Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel senomorphic agent, avenanthramide C, via the suppression of the senescence-associated secretory phenotype.
Lim JS; Lee DY; Kim HS; Park SC; Park JT; Kim HS; Oh WK; Cho KA
Mech Ageing Dev; 2020 Dec; 192():111355. PubMed ID: 32941937
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP).
Salminen A; Kauppinen A; Kaarniranta K
Cell Signal; 2012 Apr; 24(4):835-45. PubMed ID: 22182507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
